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Many errors in cell division lead to failure of cytokinesis and the generation of tetraploid 
cells. Given that tetraploidy can have deleterious consequences, such as genetic insta-
bility, we discuss the mechanisms that may have evolved to directly or indirectly prevent 
the proliferation of these cells.Cell-cycle checkpoints were origi-
nally defined as control mecha-
nisms that ensured the dependence 
of one cell-cycle event on the com-
pletion of an earlier cell-cycle event 
(Hartwell and Weinert, 1989). Two 
classic examples include the DNA 
damage checkpoint, which pre-
vents entry into mitosis in the pres-
ence of DNA damage, and the spin-
dle assembly checkpoint, which 
prevents the onset of anaphase 
prior to biorientation of all chro-
mosomes on the mitotic spindle. 
These signaling mechanisms are 
essential to protecting the integrity 
of the genome.
Over the years, a number of new 
checkpoints have been proposed, 
including a “tetraploidy checkpoint” 
that prevents cell-cycle progression 
after failed cytokinesis. An expand-
ing body of work, including studies 
in tissue culture cells, mouse mod-
els, and human patients, suggests 
that tetraploidy is a genetically 
unstable state that can precede 
the development of gross chro-
mosomal aneuploidy and facilitate 
tumorigenesis (Ganem et al., 2007). 
Many cell-cycle defects, includ-
ing progression past DNA damage 
or spindle checkpoints, can lead 
to cytokinesis failure. Thus, it has 
been appealing to postulate that a 
tetraploidy checkpoint could serve 
as the “suspenders” to the “belts” 
of earlier cell-cycle checkpoints 
and provide a final opportunity for 
these potentially dangerous cells 
to be eliminated. The existence of 
such a checkpoint, however, and the implication that cells can actu-
ally “count” the number of chromo-
somes or centrosomes, has been 
challenged. Here, we review the 
evidence for and against a specific 
tetraploid checkpoint and describe 
progress in defining mechanisms 
that prevent the proliferation of tet-
raploid cells.
p53-Dependent Cell-Cycle Arrest 
of Tetraploid Cells
The first evidence that cells pos-
sessing tetraploid DNA content 
might have a limited capacity to 
proliferate was found over 30 years 
ago, long before the importance 
of cell-cycle checkpoint controls 
was appreciated. In 1967, it was 
discovered that chemical metabo-
lites called cytochalasins (from the 
Greek words “cytos” meaning cell 
and “chalasis” meaning relaxation) 
prevented cytokinesis in mamma-
lian cells and promoted the accu-
mulation of binucleate tetraploid 
cells (Carter, 1967). Subsequent 
work supported this initial finding 
as similar experiments in different 
cell types suggested that the major-
ity of nontransformed cell lines 
accumulated as binucleate cells 
after cytochalasin-induced cytoki-
nesis failure (Wright and Hayflick, 
1972). In contrast, mammalian cells 
transformed by the SV40 T antigen 
exposed to the same cytochalasin 
treatment did not arrest as binucle-
ate tetraploids but rather continued 
to proliferate becoming multinucle-
ate. These findings implied that there 
was some SV40-dependent control Cell 131, Novon cellular ploidy. As surmised by 
Wright and Hayflick (1972): 
…once a normal human diploid 
cell becomes binucleate, intrin-
sic cell mechanisms come into 
play preventing further nuclear 
division. These cell mechanisms 
may be those altered by the 
change from a normal to a trans-
formed state. Perhaps the SV40-
transformed cells are able to 
continue nuclear division in the 
absence of cytokinesis because 
they have escaped from this 
control.
Indeed, this turned out to be true, 
as SV40 transformation was later 
shown to inactivate, among other 
proteins, p53, a key transcription 
factor that is necessary for G1 cell-
cycle arrest.
Despite these intriguing early 
findings, the phenomenon of a p53-
dependent cell-cycle arrest after 
cell division failure received little 
attention for the next 25 years. It 
was not until the mid-1990s that 
interest was rekindled, as several 
groups began to study the effects of 
spindle poisons—such as colchicine 
or nocodazole, which depolymerize 
microtubules—on cell proliferation. 
These poisons disrupt mitotic spin-
dle assembly and induce cell-cycle 
arrest by activating the spindle 
checkpoint. However, after a period 
of arrest, cells exposed to these 
poisons adapt, proceed into the 
cell cycle, fail to undergo cytokine-
sis because they cannot segregate 
their chromosomes, and enter the ember 2, 2007 ©2007 Elsevier Inc. 437
G1 phase as tetraploid cells, a series 
of steps now termed “mitotic slip-
page” (Rieder and Maiato, 2004). 
The G1 arrest of post-slippage tetra-
ploid cells requires p53 and is often 
long-lasting, most likely because of 
the induction of cellular senescence 
(Rieder and Maiato, 2004).
Studies of mitotic slippage left 
unresolved the question of why 
p53-proficient tetraploids arrest in 
G1 following mitotic slippage. Do 
cells arrest directly in response to 
the increased chromosome con-
tent, or is the arrest secondary to 
some correlated (but undefined) 
defect? To address these questions, 
Andreassen et al. (2001) revisited 
the effects of cytochalasin. Consis-
tent with the early work, transient 
dihydrocytochalasin B treatment 
resulted in G1-arrested binucle-
ate tetraploid cells, and this arrest 
was p53-dependent. Because cells 
treated with dihydrocytochalasin 
B formed normal mitotic spindles 
and underwent normal anaphase, 
the authors inferred that the main 
effect of dihydrocytochalasin B was 
to block cytokinesis. Thus, based 
on the observation that tetraploid 
cells generated by independent 
means—mitotic slippage or cytoki-
netic failure—similarly arrested in 
G1, Andreassen et al. proposed that 
cells directly monitor chromosome 
or centrosome number and coined 
the term “tetraploidy checkpoint.”
Cell-Cycle Progression in  
Tetraploids
Although the idea of a tetraploidy 
checkpoint is appealing, it has 
recently fallen out of favor. One 
confounding issue is that many tet-
raploid cells can, in fact, proliferate. 
For example, normal hepatocytes 
are often polyploid, and these cells 
are capable of undergoing mitoses 
with tetraploid or higher numbers 
of chromosome sets (Guidotti et al., 
2003). Additionally, genome dupli-
cations are frequently observed 
during the course of evolution, 
and many plants and amphibians 
can develop as newly generated 
polyploids (Storchova and Pell-
man, 2004; see Review by S. Otto 438 Cell 131, November 2, 2007 ©2007 Eon page 452 of this issue). Indeed, 
although higher vertebrates toler-
ate polyploidy poorly, there are rare 
reports of human tetraploid births 
(Storchova and Pellman, 2004).
Another issue that complicates 
the tetraploidy checkpoint idea is 
whether the drug treatments and 
synchronization procedures used 
to generate tetraploids had other 
effects that might have been the 
real triggers of the G1 arrest. This 
issue was suggested by a study 
showing that dihydrocytochalasin B 
at high concentrations could even 
arrest diploid cells in G1 (Lohez et 
al., 2003). Furthermore, cell-cycle 
arrest after induction of tetraploidy 
with cytochalasin is dependent on 
the concentration of drug used: 
whereas 10 µM cytochalasin gen-
erates binucleate tetraploid cells 
that arrest in G1, 0.5 µM cytochala-
sin produces binucleate cells that 
largely divide on schedule (Uetake 
and Sluder, 2004). Other aspects of 
the culture conditions, such as the 
strength of substrate attachment via 
fibronectin, also influence whether 
binucleate cells arrest in G1 or con-
tinue to divide. Consistent with the 
idea that tetraploid cells can divide 
normally with a tetraploid comple-
ment of chromosomes, tetraploids 
generated by cell fusion are capable 
of proliferating, at least for the first 
cell cycle after fusion (Wong and 
Stearns, 2005). Finally, cells fused 
to centrosome-containing cellular 
fragments lacking nuclei, termed 
cytoplasts, can also proliferate. 
Thus, neither doubling the number 
of chromosomes nor doubling the 
number of centrosomes necessarily 
results in arrest in G1.
These findings make it unlikely 
that a specific checkpoint directly 
counts chromosome or centrosome 
numbers. However, the fact remains 
that many manipulations that pro-
duce tetraploid cells do in fact 
activate p53 and G1 arrest. What is 
the trigger? Is it an ill-defined “off-
target” effect of the drugs, such as 
DNA damage? Although dihydro-
cytochalasin B by itself does not 
induce detectable DNA damage, 
a combination of drug treatments lsevier Inc.used to synchronize cells can (Wong 
and Stearns, 2005). However, there 
are reasons to think that drug effects 
alone cannot be the whole story. For 
example, whereas binucleate cells 
generated by high concentrations of 
dihydrocytochalasin B undergo cell-
cycle arrest, mononucleate cells in 
the same culture do not (Uetake and 
Sluder, 2004). Whatever the trigger 
for cell-cycle arrest, clearly binucle-
ate cells are more sensitive. Further-
more, many p53-proficient spon-
taneously arising tetraploids also 
undergo cell-cycle arrest (Shi and 
King, 2005). Together, these find-
ings suggest that there is some, as 
yet undefined, “abnormality” in tet-
raploid cells, and that this defect(s) 
must feed into signaling pathways 
that activate p53.
Is Tetraploidy Stressful?
Several recent studies have shed 
light on how cytoskeletal defects 
can arrest the cell cycle in G1 via p53 
and offer important clues as to why 
tetraploid cells might also tend to 
arrest in G1. In addition to the well-
understood effects of DNA damage, 
a variety of cellular stresses such 
as heat shock, osmotic shock, and 
inflammatory cytokines are also 
known to activate p53 and trigger 
G1 cell-cycle arrest. A key mediator 
of the response to these stressors 
is the p38/MAP kinase family (Zaru-
bin and Han, 2005); p38 phosphory-
lates, stabilizes, and activates p53, 
ultimately driving cell-cycle arrest, 
senescence, and/or apoptosis. Two 
recent studies demonstrated that 
abnormal centrosomes are a new 
kind of “stress” that can promote 
cell-cycle arrest through p38/MAP 
kinase. Depletion of pericentrin or 
PCM-1 (Srsen et al., 2006) or 14 of 
the 15 centrosomal components 
(Mikule et al., 2007) arrests cells via 
activation of p38, p38-dependent 
phosphorylation of p53, and accu-
mulation of p53 at centrosomes and 
in the nucleus. As expected, active 
p53 induces the cyclin-dependent 
kinase inhibitor p21, thus blocking S 
phase entry. Pharmacological inhi-
bition of p38 or genetic disruption 
of p53 or p21 abolishes the G1 cell-
cycle arrest induced by centrosome 
defects. These results led Mikule et 
al. to suggest that disruption of cen-
trosome structure and/or function 
activates a “centrosome damage” 
checkpoint that leads to a p38-de-
pendent G1 cell-cycle arrest.
New work demonstrates that cell-
cycle arrest can be achieved by the 
combined effect of several differ-
ent cellular stressors. Sluder and 
colleagues have recently revisited 
their analysis of cell-cycle progres-
sion subsequent to microsurgical 
removal of centrosomes. In contrast 
to their earlier findings, the authors 
now report that nontransformed 
human cells lacking centrosomes 
do not necessarily activate a G1 cell-
cycle arrest if cultured under the 
appropriate conditions, particularly 
if they are exposed to minimal levels 
of blue light (488 nm, used to image 
GFP) (Uetake et al., 2007). However, 
high intensity 488 nm blue light 
does induce a p38/MAP kinase-de-
pendent G1 arrest in these cells. A 
careful analysis demonstrated that 
the stress caused by centrosome 
removal and blue light exposure is 
cumulative, and that it takes a com-
bination of both factors to induce 
the full-blown p53-dependent G1 
arrest. These results illustrate a kind 
of “Heisenberg uncertainty prin-
cipal” problem that must be con-
sidered when evaluating long-term 
imaging experiments: various cel-
lular stresses may act collectively in 
cells, eventually crossing a thresh-
old of p38 activation that imposes a 
p53-dependent G1 arrest.
There are intriguing parallels 
between the story of acentrosomal 
cells and the tetraploidy checkpoint 
story. In both cases, early experi-
ments, although state-of-the-art at 
the time, involved unappreciated 
“rough treatment” of cells—blue 
light in the case of centrosome 
removal and high doses of dihydro-
cytochalasin B in the case of the 
tetraploidy checkpoint studies. In 
both cases, the result was a strong 
cell-cycle arrest response. As more 
hospitable conditions were identi-
fied, it became clear that cell-cycle 
arrest was not an obligatory end-point. Thus, although tetraploidy 
alone might be stressful, it is not 
sufficient stress to trigger cell-cy-
cle arrest. Perhaps the spontane-
ous tetraploids imaged by Shi and 
King that failed to progress through 
the cell cycle did so because they 
were experiencing the combined 
effects of tetraploidy and imag-
ing. An important test of this pos-
sibility will be to determine whether 
the cell-cycle arrest of tetraploids 
generated by high doses of dihy-
drocytochalasin B is mediated by 
p38/MAP kinase and to determine 
the potential contributions of imag-
ing and tetraploidy to the arrest of 
spontaneous tetraploids.
If tetraploidy is a weak stressor, 
we are still left asking where the 
stress originates from. One candi-
date source are extra centrosomes, 
which could produce effects similar 
to those of defective centrosomes; 
for example, defects in centrosome-
based signaling or subtle defects in 
microtubule organization. Another 
interesting possibility is abnormal 
actin and adhesion. This is sup-
ported by findings that inhibition of 
cell spreading blocks S phase entry 
(Ingber, 2003) and that increased 
fibronectin, and thus stronger adhe-
sion, reduces the likelihood that tet-
raploid cells will arrest in G1 (Uetake 
and Sluder, 2004). Because of the 
extensive interconnections between 
the centrosome, microtubules, and 
actin, it will not be trivial to deter-
mine whether there is a single pri-
mary defect. Indeed, more than one 
form of “cytoskeletal stress” could 
feed into p38 or other signaling path-
ways.
A final interesting issue concerns 
the nature of the signaling molecules 
that sense cytoskeletal stress and 
trigger p38 activation. One recently 
identified new player is the tumor 
suppressor kinase Lats2. Spindle 
damage and subsequent mitotic 
slippage after nocodazole treat-
ment cause translocation of Lats2 
from the centrosome to the nucleus, 
where it activates p53 (Aylon et al., 
2006). Interestingly, p53 is activated 
shortly after microtubule damage, 
in the G2 phase prior to mitotic slip-Cell 131, Nopage. Therefore, it appears that 
spindle damage can ramp up the 
cell-cycle arrest machinery, sen-
sitizing cells to arrest in the sub-
sequent G1. Whether Lats2 is acti-
vated in other circumstances where 
tetraploids are formed is not known. 
However, it is worth considering that 
centrosome disruption might simi-
larly promote Lats2 nuclear trans-
location. Additional candidates for 
linking cytoskeletal defects to p38 
and p53 are the Rho family of small 
GTPases: Cdc42 and Rac are known 
to be required for p38 activation in 
response to inflammatory cytokines 
(Zarubin and Han, 2005).
The Fitness of Tetraploids
Clearly, tetraploids are prone to 
cell-cycle arrest via one or more 
pathways that activate p53. How-
ever, there is another important 
factor preventing the accumulation 
of polyploid cells: in many cases, 
polyploids are less fit than their dip-
loid counterparts. For example, in 
budding yeast, diploids out-com-
pete tetraploids in long-term cul-
ture (Mable, 2001). Similarly, when 
diploid murine embryonic stem 
cells are introduced into tetraploid 
blastocysts, the diploid embryonic 
stem cells take over and produce 
a completely diploid fetus (Nagy 
et al., 1990). Polyploid cells also 
undergo apoptosis at substantially 
higher rates than diploids, and pre-
vention of apoptosis leads to a strik-
ing increase in the number of poly-
ploid cells (Castedo et al., 2006). 
Although increased ploidy generally 
results in a balanced increase in 
gene expression, tetraploid human 
colon cancer cells display a subtle 
increase in the expression of some 
p53-target genes, likely reflecting 
stress or DNA damage in a subset 
of cells (Castedo et al., 2006).
Conclusions
In animals, the proliferation of tetra-
ploid cells is limited by a variety of 
mechanisms. Tetraploid cells are gen-
erally less fit than their diploid coun-
terparts, at least in part because of 
chromosome segregation errors and 
aneuploidy. Indeed, aneuploid cells are vember 2, 2007 ©2007 Elsevier Inc. 439
less fit then their euploid parents 
(Torres et al., 2007). Without a rare 
transforming mutation, most tet-
raploid cells are expected to lose 
out in competition with diploids. In 
addition, tetraploid cells have a ten-
dency to activate a p53 response 
that leads to G1 arrest, and ulti-
mately to senescence or apopto-
sis. It appears that there is no spe-
cific tetraploidy checkpoint, in the 
sense that cells have a mechanism 
to directly count chromosomes or 
centrosomes. However, a similar 
protective effect may be achieved 
by the activation of p53 triggered 
by other cellular abnormalities that 
accompany tetraploidy (Figure 
1). Although the nature of these 
abnormalities has not been clearly 
elucidated, we suggest that an 
important source of the underlying 
defect is the cytoskeleton. We have 
reviewed several studies suggest-
ing that cytoskeletal abnormalities 
can trigger the activation of p38/
MAP kinase and thus induce p53-
dependent G1 cell-cycle arrest. 
An important emerging concept 
is that inputs into the p38 system 
are cumulative, explaining why in 
one experimental context a defect 
might trigger cell-cycle arrest 
whereas in other contexts it does not. 
If the main defect in tetraploid cells is a 
subtly abnormal cytoskeleton, then the 
response to this defect can be viewed 
as one facet of a more general signal-
ing network to monitor the integrity 
and organization of the cytoskeleton. 
We are at an early stage in elucidating 
these signaling pathways, but a better 
understanding of these signaling net-
works should shed light on a variety of 
cellular processes in development and 
cancer.
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figure 1. Keeping Tetraploid Cells in Check
Potential triggers of p53 activation that prevent the 
proliferation of tetraploid cells. Newly formed tetra-
ploid cells have extra centrosomes, increased cell 
size, and in some cases, two nuclei. These changes 
are expected to alter the organization of the cytoskele-
ton. By analogy to recent experiments on centrosome 
defects, these abnormalities may trigger p53 activa-
tion via p38/MAP kinase. Other signaling molecules, 
such as Lats2 or potentially Rho GTPases, may also 
contribute to this response.440 Cell 131, November 2, 2007 ©2007 Elsevier Inc.
